UAE Genome Program Initiates Alzheimer's Trial
InSights Research and Solutions Organization, in collaboration with the Abu Dhabi Department of Health and the American company Halia Therapeutics, has launched the first clinical trial in the UAE aimed at preventing Alzheimer's disease using genomics. The study seeks to identify at-risk individuals based on genetic data and to evaluate the preventive treatment HT-4253 in people who have not yet developed the disease, as part of efforts to improve early prevention tools and advance personalized healthcare.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)